21 May 2013
Keywords: celltech, zavesca, cleared, fda, its, partner, actelion
Article | 11 August 2003
Celltech and its partner Actelion have revealed that the US Food and Drug Administration has granted marketing authorization for Zavesca
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2003
20 May 2013
© 2013 thepharmaletter.com